Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06483230 · ClinicalTrials.gov registry record · NA

Implementation of IVS3 for Upper Limb Motor Recovery

A NA study of Motor Activity and Stroke, Cardiovascular, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06483230 is a NA study of Motor Activity and Stroke, Cardiovascular that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 25 participants, below the 76-participant average among 6 other Motor Activity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06483230, a NA study of Motor Activity and Stroke, Cardiovascular, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.

Interventions

  • DEVICE Intensive Visual Stimulation Device

Study Locations (1)

New York

  • Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106 - New York

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-10-02
Est. Completion 2027-06
Phase NA

What the Registry Record Tells You About NCT06483230

The ClinicalTrials.gov registry entry for NCT06483230 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 76-participant average among 6 other Motor Activity trials with a reported enrollment target (67% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Motor Activity appearing as the primary indexed condition, and to 1 intervention - of which Intensive Visual Stimulation Device is the first listed.

NCT06483230 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06483230 about?

NCT06483230 is a clinical study titled "Implementation of IVS3 for Upper Limb Motor Recovery". This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.

What is the current status of trial NCT06483230?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-10-02. Estimated completion is 2027-06.

What conditions does trial NCT06483230 study?

This clinical trial studies the following conditions: Motor Activity, Stroke, Cardiovascular, Neglect, Hemispatial, Mirror Movement.

What interventions are being tested in trial NCT06483230?

The interventions under investigation include: Intensive Visual Stimulation Device (DEVICE).

Who is sponsoring clinical trial NCT06483230?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06483230 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Motor Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.